Antiphospholipid antibodies in acute cardiac attacks

Abstract

Cardiovascular diseases have prevailed all over the world in the last few decades. Mortality and morbidity rates due to myocardial infarction (MI) and angina pectoris (AP) increased and affect younger ages in the present days. There are very few studies that have been carried out to define the prevalence of antiphospholipids (APLs) as a marker to help the people at risk in Saudi Arabia. The objective of our study was to examine the antiphospholipid antibodies levels on plasma including anticardiolipin antibody (